270 related articles for article (PubMed ID: 17222808)
21. Transactivation of epidermal growth factor receptor after heparin-binding epidermal growth factor-like growth factor shedding in the migration of prostate cancer cells promoted by bombesin.
Madarame J; Higashiyama S; Kiyota H; Madachi A; Toki F; Shimomura T; Tani N; Oishi Y; Matsuura N
Prostate; 2003 Nov; 57(3):187-95. PubMed ID: 14518027
[TBL] [Abstract][Full Text] [Related]
22. Muscarinic receptor agonists stimulate human colon cancer cell migration and invasion.
Belo A; Cheng K; Chahdi A; Shant J; Xie G; Khurana S; Raufman JP
Am J Physiol Gastrointest Liver Physiol; 2011 May; 300(5):G749-60. PubMed ID: 21273532
[TBL] [Abstract][Full Text] [Related]
23. LTD₄ induces HB-EGF-dependent CXCL8 release through EGFR activation in human bronchial epithelial cells.
McGovern T; Risse PA; Tsuchiya K; Hassan M; Frigola G; Martin JG
Am J Physiol Lung Cell Mol Physiol; 2010 Dec; 299(6):L808-15. PubMed ID: 20889674
[TBL] [Abstract][Full Text] [Related]
24. Heparin-binding EGF-like growth factor is an early response gene to chemotherapy and contributes to chemotherapy resistance.
Wang F; Liu R; Lee SW; Sloss CM; Couget J; Cusack JC
Oncogene; 2007 Mar; 26(14):2006-16. PubMed ID: 17001310
[TBL] [Abstract][Full Text] [Related]
25. Heparin-binding epidermal growth factor cleavage mediates zinc-induced epidermal growth factor receptor phosphorylation.
Wu W; Samet JM; Silbajoris R; Dailey LA; Sheppard D; Bromberg PA; Graves LM
Am J Respir Cell Mol Biol; 2004 Apr; 30(4):540-7. PubMed ID: 12972402
[TBL] [Abstract][Full Text] [Related]
26. 5-HT2A receptor induces ERK phosphorylation and proliferation through ADAM-17 tumor necrosis factor-alpha-converting enzyme (TACE) activation and heparin-bound epidermal growth factor-like growth factor (HB-EGF) shedding in mesangial cells.
Göőz M; Göőz P; Luttrell LM; Raymond JR
J Biol Chem; 2006 Jul; 281(30):21004-21012. PubMed ID: 16737974
[TBL] [Abstract][Full Text] [Related]
27. G Protein betagamma subunits augment UVB-induced apoptosis by stimulating the release of soluble heparin-binding epidermal growth factor from human keratinocytes.
Seo M; Lee MJ; Heo JH; Lee YI; Kim Y; Kim SY; Lee ES; Juhnn YS
J Biol Chem; 2007 Aug; 282(34):24720-30. PubMed ID: 17548351
[TBL] [Abstract][Full Text] [Related]
28. Tumor necrosis factor-alpha-stimulated membrane type 1-matrix metalloproteinase production is modulated by epidermal growth factor receptor signaling in human gingival fibroblasts.
Smith PC; Guerrero J; Tobar N; Cáceres M; González MJ; Martínez J
J Periodontal Res; 2009 Feb; 44(1):73-80. PubMed ID: 19515020
[TBL] [Abstract][Full Text] [Related]
29. Regulation of lysophosphatidic acid-induced epidermal growth factor receptor transactivation and interleukin-8 secretion in human bronchial epithelial cells by protein kinase Cdelta, Lyn kinase, and matrix metalloproteinases.
Zhao Y; He D; Saatian B; Watkins T; Spannhake EW; Pyne NJ; Natarajan V
J Biol Chem; 2006 Jul; 281(28):19501-11. PubMed ID: 16687414
[TBL] [Abstract][Full Text] [Related]
30. Heparin binding EGF is necessary for vasospastic response to endothelin.
Chansel D; Ciroldi M; Vandermeersch S; Jackson LF; Gomez AM; Henrion D; Lee DC; Coffman TM; Richard S; Dussaule JC; Tharaux PL
FASEB J; 2006 Sep; 20(11):1936-8. PubMed ID: 16877529
[TBL] [Abstract][Full Text] [Related]
31. Cell migration in response to the amino-terminal fragment of urokinase requires epidermal growth factor receptor activation through an ADAM-mediated mechanism.
Bakken AM; Protack CD; Roztocil E; Nicholl SM; Davies MG
J Vasc Surg; 2009 May; 49(5):1296-303. PubMed ID: 19394555
[TBL] [Abstract][Full Text] [Related]
32. Insulin-induced epidermal growth factor activation in vascular smooth muscle cells is ADAM-dependent.
Roztocil E; Nicholl SM; Davies MG
Surgery; 2008 Aug; 144(2):245-51. PubMed ID: 18656632
[TBL] [Abstract][Full Text] [Related]
33. A potent anti-HB-EGF monoclonal antibody inhibits cancer cell proliferation and multiple angiogenic activities of HB-EGF.
Sato S; Drake AW; Tsuji I; Fan J
PLoS One; 2012; 7(12):e51964. PubMed ID: 23251664
[TBL] [Abstract][Full Text] [Related]
34. Heparin-binding epidermal growth factor and Src family kinases in proliferation of renal epithelial cells.
Zhuang S; Kinsey GR; Rasbach K; Schnellmann RG
Am J Physiol Renal Physiol; 2008 Mar; 294(3):F459-68. PubMed ID: 18171996
[TBL] [Abstract][Full Text] [Related]
35. Injury and nucleotides induce phosphorylation of epidermal growth factor receptor: MMP and HB-EGF dependent pathway.
Boucher I; Yang L; Mayo C; Klepeis V; Trinkaus-Randall V
Exp Eye Res; 2007 Jul; 85(1):130-41. PubMed ID: 17490650
[TBL] [Abstract][Full Text] [Related]
36. TGFβ induces proHB-EGF shedding and EGFR transactivation through ADAM activation in gastric cancer cells.
Ebi M; Kataoka H; Shimura T; Kubota E; Hirata Y; Mizushima T; Mizoshita T; Tanaka M; Mabuchi M; Tsukamoto H; Tanida S; Kamiya T; Higashiyama S; Joh T
Biochem Biophys Res Commun; 2010 Nov; 402(3):449-54. PubMed ID: 20934403
[TBL] [Abstract][Full Text] [Related]
37. Involvement of metalloproteinases 2/9 in epidermal growth factor receptor transactivation in pressure-induced myogenic tone in mouse mesenteric resistance arteries.
Lucchesi PA; Sabri A; Belmadani S; Matrougui K
Circulation; 2004 Dec; 110(23):3587-93. PubMed ID: 15557365
[TBL] [Abstract][Full Text] [Related]
38. Neuropeptide-induced transactivation of a neuronal epidermal growth factor receptor is mediated by metalloprotease-dependent formation of heparin-binding epidermal growth factor.
Shah BH; Farshori MP; Catt KJ
J Biol Chem; 2004 Jan; 279(1):414-20. PubMed ID: 14573593
[TBL] [Abstract][Full Text] [Related]
39. Membrane-bound heparin-binding epidermal growth factor like growth factor regulates E-cadherin expression in pancreatic carcinoma cells.
Wang F; Sloss C; Zhang X; Lee SW; Cusack JC
Cancer Res; 2007 Sep; 67(18):8486-93. PubMed ID: 17875687
[TBL] [Abstract][Full Text] [Related]
40. M2 macrophages induce ovarian cancer cell proliferation via a heparin binding epidermal growth factor/matrix metalloproteinase 9 intercellular feedback loop.
Carroll MJ; Kapur A; Felder M; Patankar MS; Kreeger PK
Oncotarget; 2016 Dec; 7(52):86608-86620. PubMed ID: 27888810
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
